Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin.

Munoz-Zuluaga CA, King MC, Ledakis P, Gushchin V, Sittig M, Nieroda C, Zambrano-Vera K, Sardi A.

Eur J Surg Oncol. 2019 May 9. pii: S0748-7983(19)30446-9. doi: 10.1016/j.ejso.2019.05.008. [Epub ahead of print]

PMID:
31109821
2.

Selection and Characteristics of Patients with Peritoneal Dissemination from Appendiceal Cancer with Exceptional/Poor Survival After CRS/HIPEC.

Munoz-Zuluaga C, King MC, Sardi A, Ledakis P, Sittig M, Nieroda C, MacDonald R, Gushchin V.

Ann Surg Oncol. 2019 Apr 30. doi: 10.1245/s10434-019-07374-z. [Epub ahead of print]

PMID:
31041628
3.

Pre- and post-operative antibiotics in conjunction with cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC) should be considered for pseudomyxoma peritonei (PMP) treatment.

Merrell DS, McAvoy TJ, King MC, Sittig M, Millar EV, Nieroda C, Metcalf JL, Blum FC, Testerman TL, Sardi A.

Eur J Surg Oncol. 2019 Jan 30. pii: S0748-7983(19)30249-5. doi: 10.1016/j.ejso.2019.01.223. [Epub ahead of print]

PMID:
30770164
4.

Comparison of Survival in Patients with Isolated Peritoneal Carcinomatosis from Colorectal Cancer Treated with Cytoreduction and Melphalan or Mitomycin-C as Hyperthermic Intraperitoneal Chemotherapy Agent.

Sipok A, Sardi A, Nieroda C, King MC, Sittig M, Gushchin V.

Int J Surg Oncol. 2018 Dec 13;2018:1920276. doi: 10.1155/2018/1920276. eCollection 2018.

5.

Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Munoz-Zuluaga C, Sardi A, King MC, Nieroda C, Sittig M, MacDonald R, Gushchin V.

Ann Surg Oncol. 2019 Feb;26(2):473-481. doi: 10.1245/s10434-018-7007-3. Epub 2018 Dec 6.

PMID:
30523470
6.

Efficacy of Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Treatment of Recurrent Uterine Sarcoma.

Díaz-Montes TP, El-Sharkawy F, Lynam S, Harper A, Sittig M, MacDonald R, Gushchin V, Sardi A.

Int J Gynecol Cancer. 2018 Jul;28(6):1130-1137. doi: 10.1097/IGC.0000000000001289.

PMID:
29975291
7.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma.

Sardi A, Muñoz-Zuluaga CA, Sittig M, Diaz-Montes T.

Clin Case Rep. 2018 May 2;6(6):1142-1152. doi: 10.1002/ccr3.1491. eCollection 2018 Jun.

8.

Misdiagnosis of a hidden cause of hypertension: a case report.

de Lima A, El-Sharkawy F, Nieroda C, Sardi A.

Br J Gen Pract. 2017 Dec;67(665):578-579. doi: 10.3399/bjgp17X693869. No abstract available. Erratum in: Br J Gen Pract. 2018 Jan;68(666):15.

9.

Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Sardi A, Sipok A, Baratti D, Deraco M, Sugarbaker P, Salti G, Yonemura Y, Sammartino P, Glehen O, Bakrin N, Díaz-Montes TP, Gushchin V.

Eur J Surg Oncol. 2017 Nov;43(11):2170-2177. doi: 10.1016/j.ejso.2017.08.011. Epub 2017 Sep 7.

PMID:
28967566
10.

Concerning CT features used to select patients for treatment of peritoneal metastases, a pictoral essay.

Sugarbaker PH, Sardi A, Brown G, Dromain C, Rousset P, Jelinek JS.

Int J Hyperthermia. 2017 Aug;33(5):497-504. doi: 10.1080/02656736.2017.1317368.

PMID:
28540832
11.

External Validation of the Simplified Preoperative Assessment for Low-Grade Mucinous Adenocarcinoma of the Appendix.

Milovanov V, Sardi A, Aydin N, Nieroda C, Sittig M, Gushchin V.

Ann Surg Oncol. 2017 Jul;24(7):1783-1786. doi: 10.1245/s10434-017-5794-6. Epub 2017 Mar 17.

PMID:
28315061
12.

Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma: Experience of a Peritoneal Surface Malignancy Center.

Aydin N, Sardi A, Milovanov V, Nieroda C, Sittig M, Nunez MF, Jimenez W, Gushchin V.

Am Surg. 2015 Dec;81(12):1253-9.

PMID:
26736164
13.

The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).

Milovanov V, Sardi A, Studeman K, Nieroda C, Sittig M, Gushchin V.

Ann Surg Oncol. 2016 Jun;23(6):1928-33. doi: 10.1245/s10434-015-5047-5. Epub 2015 Dec 29.

PMID:
26714951
14.

A Novel Member of Chitinophagaceae Isolated from a Human Peritoneal Tumor.

Lo AS, Merrell DS, Lei H, Sardi A, McAvoy T, Testerman TL.

Genome Announc. 2015 Nov 12;3(6). pii: e01297-15. doi: 10.1128/genomeA.01297-15.

15.

Port-site metastases is an independent prognostic factor in patients with peritoneal carcinomatosis.

Nunez MF, Sardi A, Jimenez W, Nieroda C, Sittig M, MacDonald R, Aydin N, Milovanov V, Gushchin V.

Ann Surg Oncol. 2015 Apr;22(4):1267-73. doi: 10.1245/s10434-014-4136-1. Epub 2014 Oct 16.

PMID:
25319578
16.

Morbidity of the abdominal wall resection and reconstruction after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).

Nunez MF, Sardi A, Nieroda C, Jimenez W, Sittig M, MacDonald R, Aydin N, Milovanov V, Gushchin V.

Ann Surg Oncol. 2015 May;22(5):1658-63. doi: 10.1245/s10434-014-4075-x. Epub 2014 Sep 23.

PMID:
25245127
17.
18.

The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.

Prada-Villaverde A, Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spiliotis J, Torres-Melero J, Turaga K, Trout R.

J Surg Oncol. 2014 Dec;110(7):779-85. doi: 10.1002/jso.23728. Epub 2014 Aug 2.

PMID:
25088304
19.

Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Jimenez W, Sardi A, Nieroda C, Sittig M, Milovanov V, Nunez M, Aydin N, Gushchin V.

Ann Surg Oncol. 2014 Dec;21(13):4218-25. doi: 10.1245/s10434-014-3869-1. Epub 2014 Jul 2.

PMID:
24986239
20.

The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis.

Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spilioitis J, Torres-Melero J, Turaga K, Trout R.

Ann Surg Oncol. 2014 Dec;21(13):4195-201. doi: 10.1245/s10434-014-3798-z. Epub 2014 May 23.

PMID:
24854493

Supplemental Content

Loading ...
Support Center